한글목차

디지털 치료법 자궁내막증 시장 규모는 최근 급격하게 확대하고 있습니다. 2025년 17억 달러에서 2026년에는 20억 9,000만 달러로, CAGR 22.5%로 성장할 것으로 예상됩니다. 지난 수년간의 성장에는 자궁내막증 진단 증가, 모바일 건강 애플리케이션의 사용 확대, 비침습적 치료법에 대한 환자 수요 증가, 디지털 치료제의 조기 규제 승인, 여성용 헬스케어 디지털 플랫폼의 확대 등이 주요 요인으로 작용한 것으로 보입니다.

디지털 치료법 자궁내막증 시장 규모는 향후 몇 년간 급격한 성장이 전망됩니다. 2030년에는 46억 5,000만 달러에 달하고, CAGR은 22.2%가 될 전망입니다. 예측 기간 동안 성장 요인으로는 디지털 자궁내막증 치료법의 임상적 유효성 검증 증가, 장기적인 질병 관리 도구에 대한 수요 증가, 클라우드 기반 디지털 헬스 플랫폼의 확대, 웨어러블 건강 기기와의 연계 강화, 지불 기관 및 의료 서비스 제공자 채택 증가 등을 꼽았습니다. 예측 기간의 주요 동향으로는 개인화된 디지털 치료 프로그램 도입 증가, 증상 및 불임 추적 애플리케이션 사용 확대, 행동 치료 플랫폼 확대, 원격의료 및 원격 상담 도구의 통합 촉진, 환자 교육 및 참여에 대한 집중 강화 등을 들 수 있습니다.

스마트폰의 급속한 보급이 향후 몇 년 동안 디지털 치료법을 이용한 자궁내막증 시장의 성장을 견인할 것으로 예상됩니다. 스마트폰은 통신 기능, 인터넷 접속 기능, 컴퓨팅 기능을 하나의 기기에 통합한 휴대용 단말기입니다. 인터넷 보급률의 증가로 더 많은 사람들이 디바이스를 통해 온라인 서비스, 소셜 미디어, 디지털 엔터테인먼트에 편리하게 접근할 수 있게 되면서 스마트폰의 사용 증가를 촉진하고 있습니다. 스마트폰의 보급 확대는 자궁내막증에 대한 디지털 치료제를 뒷받침하고 있으며, 사용자가 개인화된 치료 애플리케이션에 쉽고 지속적으로 접근할 수 있고, 언제 어디서나 실시간 증상 추적, 데이터 모니터링, 근거에 기반한 치료 지침을 받을 수 있게함으로써 자궁내막증에 대한 디지털 치료제를 지원하고 있습니다. 예를 들어, 2023년 2월 영국에 본사를 둔 온라인 전화 비교 및 전환 서비스 제공 업체인 Uswitch Limited가 발표한 보고서에 따르면, 2022년에는 7,180만 개의 활성 모바일 연결이 있을 것으로 예상되며, 2025년까지 영국 인구 6,830만 명의 95%가 스마트폰을 소유할 것으로 예상됩니다. 가 스마트폰을 소유할 것으로 예상됩니다. 그 결과, 스마트폰의 급속한 보급이 디지털 치료법에서 자궁내막증 시장의 성장을 촉진할 것으로 예상됩니다.

디지털 치료법으로 자궁내막증 시장에서 사업을 전개하는 주요 기업들은 다양한 관점과 전문성을 결합하여 혁신을 가속화하기 위해 전략적 제휴를 구축하는 데 주력하고 있습니다. 협업이란 여러 당사자가 공동의 목표 달성, 자원 공유, 상호 강점 활용을 목적으로 협력하는 파트너십을 말합니다. 예를 들어, 2024년 3월 호주의 국가 공인 자선단체인 자궁내막증 호주(Endometriosis Australia)는 호주의 디지털 건강 기업 찰리(CHARLI)와 제휴하여 자궁내막증으로 고통받는 수천 명의 호주인들을 지원하기 위한 혁신적인 플랫폼을 출시했습니다. 이 협업을 통해 의료 및 건강 전문가와 소비자가 공동으로 개발한 앱이 탄생했습니다. 이 앱은 AI를 활용하여 여성의 생리주기, 임신 가능성, 성 건강, 임신, 갱년기/폐경기를 관리할 수 있도록 도와줍니다. 또한, 자궁내막증과 같은 통증이나 잠재적 질환을 파악하는 데도 도움이 됩니다. 자궁내막증 호주와의 파트너십을 통해 자궁내막증으로 고통받는 호주인 7명 중 1명에게 보다 빠른 진단과 의료 서비스를 쉽게 이용할 수 있도록 돕고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Digital therapeutics for endometriosis refer to clinically validated digital health solutions that leverage technology and data-driven methods to manage the condition effectively. These therapeutics are created based on scientific research and behavioral science principles to provide personalized, evidence-based treatment programs. They aim to tackle the physical, emotional, and lifestyle challenges linked to endometriosis while complying with regulatory requirements for safety and clinical efficacy.

The primary product categories of digital therapeutics for endometriosis include software, devices, and services. Software includes digital programs, platforms, and mobile applications created to provide therapeutic interventions and healthcare management solutions. It is available in different deployment modes, such as on-premises and cloud-based, and is utilized for pain management, symptom tracking, fertility management, education and awareness, among other applications. It is used by a variety of end users, including hospitals and clinics, homecare providers, research institutes, and others.

Tariffs are influencing the digital therapeutics endometriosis market by increasing costs of imported wearable devices, diagnostic sensors, and supporting hardware used alongside software platforms. Digital health companies and healthcare systems in North America and Europe are most affected due to dependence on imported components, while Asia-Pacific faces cost pressure in device manufacturing and distribution. These tariffs are raising overall solution costs and slowing adoption of device-supported digital therapies. However, they are also encouraging software-centric innovation, localized device sourcing, and increased reliance on cloud-based and platform-driven therapeutic models.

The digital therapeutics endometriosis market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics endometriosis market statistics, including digital therapeutics endometriosis industry global market size, regional shares, competitors with a digital therapeutics endometriosis market share, detailed digital therapeutics endometriosis market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics endometriosis industry. This digital therapeutics endometriosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital therapeutics endometriosis market size has grown exponentially in recent years. It will grow from $1.7 billion in 2025 to $2.09 billion in 2026 at a compound annual growth rate (CAGR) of 22.5%. The growth in the historic period can be attributed to growing prevalence of endometriosis diagnosis, increased use of mobile health applications, rising patient demand for non-invasive management options, early regulatory acceptance of digital therapeutics, expansion of women's health digital platforms.

The digital therapeutics endometriosis market size is expected to see exponential growth in the next few years. It will grow to $4.65 billion in 2030 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to increasing clinical validation of digital endometriosis therapies, rising demand for long-term condition management tools, expansion of cloud-based digital health platforms, growing integration with wearable health devices, increasing payer and provider adoption. Major trends in the forecast period include increasing adoption of personalized digital treatment programs, growing use of symptom and fertility tracking applications, expansion of behavior-based therapy platforms, rising integration of remote care and teleconsultation tools, enhanced focus on patient education and engagement.

The rapid adoption of smartphones is anticipated to drive the growth of the digital therapeutics endometriosis market in the coming years. Smartphones are portable devices that combine communication, internet connectivity, and computing capabilities into a single device. The increase in smartphone usage is driven by rising internet penetration, which enables more people to conveniently access online services, social media, and digital entertainment through their devices. Widespread smartphone adoption supports digital therapeutics for endometriosis by giving users easy and continuous access to personalized therapeutic applications, allowing real-time symptom tracking, data monitoring, and evidence-based treatment guidance anytime and anywhere. For example, in February 2023, a report by Uswitch Limited, a UK-based online and telephone comparison and switching service provider, noted that there were 71.8 million active mobile connections in 2022, and by 2025, it is projected that 95% of the 68.3 million people in the UK will own smartphones. As a result, the rapid adoption of smartphones is expected to drive the growth of the digital therapeutics endometriosis market.

Major companies operating in the digital therapeutics endometriosis market are concentrating on forming strategic collaborations to accelerate innovation by combining diverse perspectives and specialized expertise. Collaborations involve partnerships where multiple parties work together to achieve common goals, pool resources, or leverage each other's strengths. For example, in March 2024, Endometriosis Australia, an Australia-based nationally accredited charity, partnered with CHARLI, an Australia-based digital health company, to launch a transformative platform designed to support thousands of Australians affected by endometriosis. This collaboration led to the creation of an app developed by medical and health experts in conjunction with consumers. The app utilizes AI to help women track menstruation, fertility, sexual health, pregnancy, and peri/menopause. It also assists in identifying pain or potential conditions such as endometriosis. Through its partnership with Endometriosis Australia, it provides support to the one in seven Australians affected by the condition, facilitating faster diagnosis and easier access to care.

In March 2023, Chugai Pharmaceutical Co. Ltd., a Japan-based research and development-focused pharmaceutical company, collaborated with Biofourmis to concentrate on data-driven virtual care for endometriosis-related pain. Through this collaboration, Chugai Pharmaceutical and Biofourmis aim to create and implement digital therapeutics that objectively monitor and manage pain in patients with endometriosis, enhancing treatment outcomes and quality of life. Biofourmis is a US-based digital therapeutics company that develops digital solutions for evaluating and managing pain associated with endometriosis.

Major companies operating in the digital therapeutics endometriosis market are Bayer AG, Kissei Pharmaceutical Co. Ltd., Abbott Laboratories, Luna Endoscore, Chugai Pharmaceutical Co. Ltd., Sword health inc., Charli , Maven Clinic Co., Flo Health Inc., Hinge Health Inc., PrecisionLife Ltd., TiumBio, EpicentRx Inc., Syrona Health, Matilda Health Care, ELANZA Wellness Inc., iCareBetter Inc., Endocare Clinic Fz LLc, Herabiotech, Ziwig Biotech, Hera Biotech Inc.

North America was the largest region in the digital therapeutics endometriosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics endometriosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the digital therapeutics endometriosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital therapeutics endometriosis market consists of revenues earned by entities by providing services such as personalized treatment programs, hormonal health management, teleconsultation support, and mental health support. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics endometriosis market also includes sales of smart ring monitors, implantable sensor devices, wireless hormone monitoring biosensor, and wearable sleep tracker. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics Endometriosis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses digital therapeutics endometriosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics endometriosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics endometriosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Software; Devices; Services
• 2) By Deployment Mode: On-Premises; Cloud-Based
• 3) By Application: Pain Management; Symptom Tracking; Fertility Management; Education And Awareness; Other Applications
• 4) By End User: Hospitals And Clinics; Homecare; Research Institutes; Other End Users
• Subsegments:
• 1) By Software: Mobile Applications; Web-Based Platforms; Cloud-Based Solutions; Decision Support Tools
• 2) By Devices: Wearable Monitoring Devices; Smart Therapeutic Devices; Digital Diagnostic Tools; Connected Medical Devices
• 3) By Services: Remote Patient Monitoring Services; Teleconsultation Services; Therapy Management Services; Data Analytics And Support Services
• Companies Mentioned: Bayer AG; Kissei Pharmaceutical Co. Ltd.; Abbott Laboratories; Luna Endoscore; Chugai Pharmaceutical Co. Ltd.; Sword health inc.; Charli ; Maven Clinic Co.; Flo Health Inc.; Hinge Health Inc.; PrecisionLife Ltd.; TiumBio; EpicentRx Inc.; Syrona Health; Matilda Health Care; ELANZA Wellness Inc.; iCareBetter Inc.; Endocare Clinic Fz LLc; Herabiotech; Ziwig Biotech; Hera Biotech Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Digital Therapeutics Endometriosis Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Digital Therapeutics Endometriosis Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Digital Therapeutics Endometriosis Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Digital Therapeutics Endometriosis Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Biotechnology, Genomics & Precision Medicine
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Personalized Digital Treatment Programs
  • 4.2.2 Growing Use Of Symptom And Fertility Tracking Applications
  • 4.2.3 Expansion Of Behavior-Based Therapy Platforms
  • 4.2.4 Rising Integration Of Remote Care And Teleconsultation Tools
  • 4.2.5 Enhanced Focus On Patient Education And Engagement

5. Digital Therapeutics Endometriosis Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Homecare Providers
• 5.3 Research Institutes
• 5.4 Women'S Health Centers
• 5.5 Digital Health Companies

6. Digital Therapeutics Endometriosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Digital Therapeutics Endometriosis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Digital Therapeutics Endometriosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Digital Therapeutics Endometriosis Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Digital Therapeutics Endometriosis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Digital Therapeutics Endometriosis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Digital Therapeutics Endometriosis Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Digital Therapeutics Endometriosis Market Segmentation

• 9.1. Global Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Software, Devices, Services
• 9.2. Global Digital Therapeutics Endometriosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• On-Premises, Cloud-Based
• 9.3. Global Digital Therapeutics Endometriosis Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pain Management, Symptom Tracking, Fertility Management, Education And Awareness, Other Applications
• 9.4. Global Digital Therapeutics Endometriosis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Homecare, Research Institutes, Other End Users
• 9.5. Global Digital Therapeutics Endometriosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Mobile Applications, Web-Based Platforms, Cloud-Based Solutions, Decision Support Tools
• 9.6. Global Digital Therapeutics Endometriosis Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Wearable Monitoring Devices, Smart Therapeutic Devices, Digital Diagnostic Tools, Connected Medical Devices
• 9.7. Global Digital Therapeutics Endometriosis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Remote Patient Monitoring Services, Teleconsultation Services, Therapy Management Services, Data Analytics And Support Services

10. Digital Therapeutics Endometriosis Market Regional And Country Analysis

• 10.1. Global Digital Therapeutics Endometriosis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Digital Therapeutics Endometriosis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Digital Therapeutics Endometriosis Market

• 11.1. Asia-Pacific Digital Therapeutics Endometriosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Digital Therapeutics Endometriosis Market

• 12.1. China Digital Therapeutics Endometriosis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Digital Therapeutics Endometriosis Market

• 13.1. India Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Digital Therapeutics Endometriosis Market

• 14.1. Japan Digital Therapeutics Endometriosis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Digital Therapeutics Endometriosis Market

• 15.1. Australia Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Digital Therapeutics Endometriosis Market

• 16.1. Indonesia Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Digital Therapeutics Endometriosis Market

• 17.1. South Korea Digital Therapeutics Endometriosis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Digital Therapeutics Endometriosis Market

• 18.1. Taiwan Digital Therapeutics Endometriosis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Digital Therapeutics Endometriosis Market

• 19.1. South East Asia Digital Therapeutics Endometriosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Digital Therapeutics Endometriosis Market

• 20.1. Western Europe Digital Therapeutics Endometriosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Digital Therapeutics Endometriosis Market

• 21.1. UK Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Digital Therapeutics Endometriosis Market

• 22.1. Germany Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Digital Therapeutics Endometriosis Market

• 23.1. France Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Digital Therapeutics Endometriosis Market

• 24.1. Italy Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Digital Therapeutics Endometriosis Market

• 25.1. Spain Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Digital Therapeutics Endometriosis Market

• 26.1. Eastern Europe Digital Therapeutics Endometriosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Digital Therapeutics Endometriosis Market

• 27.1. Russia Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Digital Therapeutics Endometriosis Market

• 28.1. North America Digital Therapeutics Endometriosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Digital Therapeutics Endometriosis Market

• 29.1. USA Digital Therapeutics Endometriosis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Digital Therapeutics Endometriosis Market

• 30.1. Canada Digital Therapeutics Endometriosis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Digital Therapeutics Endometriosis Market

• 31.1. South America Digital Therapeutics Endometriosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Digital Therapeutics Endometriosis Market

• 32.1. Brazil Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Digital Therapeutics Endometriosis Market

• 33.1. Middle East Digital Therapeutics Endometriosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Digital Therapeutics Endometriosis Market

• 34.1. Africa Digital Therapeutics Endometriosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Digital Therapeutics Endometriosis Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Digital Therapeutics Endometriosis Market Regulatory and Investment Landscape

36. Digital Therapeutics Endometriosis Market Competitive Landscape And Company Profiles

• 36.1. Digital Therapeutics Endometriosis Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Digital Therapeutics Endometriosis Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Digital Therapeutics Endometriosis Market Company Profiles
  • 36.3.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Kissei Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Luna Endoscore Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Chugai Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Digital Therapeutics Endometriosis Market Other Major And Innovative Companies

• Sword health inc., Charli, Maven Clinic Co., Flo Health Inc., Hinge Health Inc., PrecisionLife Ltd., TiumBio, EpicentRx Inc., Syrona Health, Matilda Health Care, ELANZA Wellness Inc., iCareBetter Inc., Endocare Clinic Fz LLc, Herabiotech, Ziwig Biotech

38. Global Digital Therapeutics Endometriosis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Digital Therapeutics Endometriosis Market

40. Digital Therapeutics Endometriosis Market High Potential Countries, Segments and Strategies

• 40.1 Digital Therapeutics Endometriosis Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Digital Therapeutics Endometriosis Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Digital Therapeutics Endometriosis Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer